Work is underway to create a collaborative virtual research institute (VRI) to support the fundamental research and subsequent clinical translation of precision medicine in Abu Dhabi, as well as the United Arab Emirates more broadly. Here, European Pharmaceutical Review’s Hannah Balfour discusses the project with the Head of the new VRI, Professor Milos Ljubisavljevic, and Acting CEO of funding body ASPIRE, Dr Ray O. Johnson.